Search company, investor...

TechniScan Medical Systems

Founded Year



Series E - II | Alive

Total Raised


Last Raised

$1.1M | 13 yrs ago

About TechniScan Medical Systems

TechniScan has developed a whole breast ultrasound imaging system

Headquarters Location

3216 South Highland Drive Suite 200

Salt Lake City, Utah, 84106,

United States


Missing: TechniScan Medical Systems's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: TechniScan Medical Systems's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

TechniScan Medical Systems Patents

TechniScan Medical Systems has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Acoustics, Medical imaging, Wave mechanics, Electromagnetism, Waves


Application Date


Grant Date



Related Topics

Acoustics, Medical imaging, Wave mechanics, Electromagnetism, Waves



TechniScan Medical Systems Frequently Asked Questions (FAQ)

  • When was TechniScan Medical Systems founded?

    TechniScan Medical Systems was founded in 1984.

  • Where is TechniScan Medical Systems's headquarters?

    TechniScan Medical Systems's headquarters is located at 3216 South Highland Drive, Salt Lake City.

  • What is TechniScan Medical Systems's latest funding round?

    TechniScan Medical Systems's latest funding round is Series E - II.

  • How much did TechniScan Medical Systems raise?

    TechniScan Medical Systems raised a total of $7.5M.

  • Who are the investors of TechniScan Medical Systems?

    Investors of TechniScan Medical Systems include The Esaote Group, Imaging Technology Ventures and Maxim Group.

  • Who are TechniScan Medical Systems's competitors?

    Competitors of TechniScan Medical Systems include Gammex, Ultrasound Medical Devices, Insight Imaging, Orison, Real Imaging and 13 more.

Compare TechniScan Medical Systems to Competitors

Micrima Logo

Micrima is a Bristol-based company developing a safe, low-cost system to improve the detection of breast cancer. The imaging system captures high-resolution, 3D images through the use of harmless radio waves. The safe, low-cost system enables women of all ages to be screened for breast cancer in GP surgeries, or alternative high street locations, with results that are now comparable with traditional X-ray mammograms.

Ultrasound Medical Devices

Ultrasound Medical Devices, dba Epsilon Imaging, develops imaging technologies that pair visualization of diagnostic information with quantitative data to yield greater understanding and insight into a patient's condition. The company's goal is to provide tools that enable earlier detection and more accurate diagnosis of health issues, improving patient care and lowering treatment costs.

Seno Medical Instruments

Seno Medical was formed to commercialize a new modality in cancer screening and diagnosis: laser opto-acoustic imaging. Unlike most screening techniques, which rely on anatomical imaging, Seno's goal is to bring functional imaging that can detect angiogenesis to the marketplace. Products for use with humans, focusing initially on breast cancer, are also in development for subsequent testing. Seno's patented technology integrates the use of lasers and acoustics to determine the presence of angiogenesis - the growth of blood vessels and higher blood volume that always surrounds a tumor. Per the company, unlike anatomical imaging techniques, such as mammography, laser opto-acoustic imaging can detect breast cancer, for example, at its earliest clinically stage (2 mm. versus 10 mm. with mammography) without patient discomfort or exposure to harmful x-ray.


Gammex is engaged in manufacturing and distribution of quality control devices for ultrasound, mammography, medical imaging and laser alignment systems.

Microwave Imaging System Technologies (MIST)

Microwave Imaging Systems Technology was founded in 1995 by Dr. Keith Paulsen and Dr. Paul Meaney of the Thayer School of Engineering and has developed a microwave-based, breast imaging system which aims to provide high-contrast images for breast cancer diagnostics. Per the company, the NIH has invested more than $6 million to develop and demonstrate the MIST system for tumor imaging. The company reports that testing on more than 150 patients has shown excellent detection of breast tumors.

FMI Medical Systems

FMI Medical Systems is developing ultra high resolution PET/CT/SPECT diagnostic imaging systems combined with drugs and molecular tracers for earliest detection and monitoring of Alzheimer's, neurodegenerative disorders, and head and neck cancers and breast cancer.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.